CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Porton Pharma Solutions Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Porton Pharma Solutions Ltd
No. 7, Yuntu Road, Beibei District
Phone: +86 2365936900p:+86 2365936900 CHONGQING, CHO  400714  China Ticker: 300363300363
Business Summary
Porton Pharma Solutions Ltd is a China-based company principally engaged in small molecule active pharmaceutical ingredient (API) business, small molecule preparation business, gene cell therapy business and new molecule business. The small molecule API business mainly provides research, development and production services for starting materials, intermediates and APIs. The small molecule preparation business mainly provides research, development and production services such as small molecule drug preparation prescription process development and optimization, as well as co-development services. The gene cell therapy business mainly includes contract development and manufacturing organization (CDMO) platforms such as plasmids and cell therapy. The new molecule business mainly provides research, development and production services for drugs such as peptides. The Company mainly operates its businesses in the domestic and overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202512/31/2024Yes---Yes

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager NianfengJu 52 11/27/2009 11/27/2009
Finance Director, Deputy General Manager HuiChen 46 4/22/2022 4/22/2022
Chief Operating Officer, Senior Deputy General Manager YinchunBai 52 4/22/2022 4/22/2022
8 additional Officers and Directors records available in full report.

Business Names
Business Name
300363
Porton Americas, Inc.

General Information
Number of Employees: 4,214 (As of 12/31/2024)
Outstanding Shares: 545,464,520 (As of 6/30/2025)
Shareholders: 46,400
Stock Exchange: SHE
Fax Number: +86 2365936901


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, September 5, 2025
Register now for our FAST Rating webinar on September 10 at 2:00 PM ET!